These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 20730893)
1. Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors. Yuan Y; Leszczynska M; Konstantinovsky S; Tropé CG; Reich R; Davidson B Diagn Cytopathol; 2011 Aug; 39(8):562-6. PubMed ID: 20730893 [TBL] [Abstract][Full Text] [Related]
2. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells. Davidson B; Baekelandt M; Shih IeM Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338 [TBL] [Abstract][Full Text] [Related]
3. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863 [TBL] [Abstract][Full Text] [Related]
4. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions. Bock AJ; Nymoen DA; Brenne K; Kærn J; Davidson B Hum Pathol; 2012 May; 43(5):669-74. PubMed ID: 21855113 [TBL] [Abstract][Full Text] [Related]
5. Kallikrein 4 is expressed in malignant mesothelioma--further evidence for the histogenetic link between mesothelial and epithelial cells. Davidson B; Xi Z; Saatcioglu F Diagn Cytopathol; 2007 Feb; 35(2):80-4. PubMed ID: 17230566 [TBL] [Abstract][Full Text] [Related]
6. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions. Davidson B; Xi Z; Klokk TI; Tropé CG; Dørum A; Scheistrøen M; Saatcioglu F Am J Clin Pathol; 2005 Mar; 123(3):360-8. PubMed ID: 15716231 [TBL] [Abstract][Full Text] [Related]
7. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575 [TBL] [Abstract][Full Text] [Related]
8. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications. Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079 [TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions. Elstrand MB; Stavnes HT; Tropé CG; Davidson B Hum Pathol; 2012 Apr; 43(4):529-35. PubMed ID: 21864883 [TBL] [Abstract][Full Text] [Related]
10. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938 [TBL] [Abstract][Full Text] [Related]
11. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Davidson B; Reich R; Lazarovici P; Ann Flørenes V; Nielsen S; Nesland JM Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities. Reich R; Vintman L; Nielsen S; Kaern J; Bedrossian C; Berner A; Davidson B Diagn Cytopathol; 2005 Nov; 33(5):332-7. PubMed ID: 16240397 [TBL] [Abstract][Full Text] [Related]
13. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863 [TBL] [Abstract][Full Text] [Related]
14. Pax8: a marker for carcinoma of Müllerian origin in serous effusions. Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters. Dong HP; Holth A; Kleinberg L; Ruud MG; Elstrand MB; Tropé CG; Davidson B; Risberg B Am J Clin Pathol; 2009 Nov; 132(5):756-62. PubMed ID: 19846818 [TBL] [Abstract][Full Text] [Related]
16. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival. Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507 [TBL] [Abstract][Full Text] [Related]
17. Angiogenic molecule expression is downregulated in effusions from breast cancer patients. Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions. Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847 [TBL] [Abstract][Full Text] [Related]
19. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions. Kleinberg L; Flørenes VA; Nesland JM; Davidson B Am J Clin Pathol; 2007 Sep; 128(3):389-97. PubMed ID: 17709312 [TBL] [Abstract][Full Text] [Related]
20. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma. Davidson B; Shih IeM; Wang TL Hum Pathol; 2008 Nov; 39(11):1630-6. PubMed ID: 18656238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]